The bioavailability of an ophthalmologically active compound is increased by its provision in a dosage of ophthalmic treatment liquid which takes the form of a jet or stream of droplets. Such a jet or stream can be directed or targeted at a particular site in the eye where the compound can be best absorbed.
申请公布号
WO9723177(A1)
申请公布日期
1997.07.03
申请号
WO1996GB03195
申请日期
1996.12.20
申请人
R.P. SCHERER LIMITED;EMBLETON, JONATHAN, KENNETH;MALCOLMSON, RICHARD, JOSEPH;MARTINI, LUIGI, GERARD, ANTHONY
发明人
EMBLETON, JONATHAN, KENNETH;MALCOLMSON, RICHARD, JOSEPH;MARTINI, LUIGI, GERARD, ANTHONY
